Global Vascular Grafts Market to Reach US$4.4 Billion by the Year 2026
Abstract: Global Vascular Grafts Market to Reach US$4. 4 Billion by the Year 2026 . Vascular grafts are implants that are used during surgical procedures that involve peripheral vessel bypass or aortic repair.
New York, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vascular Grafts Industry" - https://www.reportlinker.com/p05896475/?utm_source=GNW
They are synthetic tubes that are surgically implanted in the arteries and veins to repair diseased or injured areas in the arteries. Vascular grafts are also used to patch up whole segments of the aorta and other larger arteries. By harnessing the vascular grafts, damaged or diseased blood vessels are replaced or patched up to redirect the blood flow. Vascular grafts come in an array of materials, such as biosynthetic, polyester, polyurethane, and polytetrafluoroethylene (ePTFE). While vascular grafts are largely used in the heart during a coronary artery bypass, they are also deployed to treat renal failure, vascular occlusion, vascular disease, and aneurysm. The increasing prevalence of diabetes, hypertension, vascular occlusions, end-stage renal disease, and peripheral artery diseases has been a growth driver for the vascular graft treatment market. There is greater public awareness of coronary diseases brought about by sedentary lifestyles, unhealthy eating habits, and smoking. Vascular grafts are also deployed for kidney transplants for repairing renal vessels.
Amid the COVID-19 crisis, the global market for Vascular Grafts estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2026, growing at a CAGR of 6.4% over the analysis period. Endovascular Aneurysm Repair (EVAR), one of the segments analyzed in the report, is projected to grow at a 6.2% CAGR to reach US$2.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Vascular Repair segment is readjusted to a revised 8% CAGR for the next 7-year period. This segment currently accounts for a 32.7% share of the global Vascular Grafts market. The endovascular grafts dominated market share, fueled by the surging demand for sophisticated endovascular grafts. Anaconda AAA Stent Graft System of Terumo and Endurant II AAA Stent Graft System of Medtronic are the main products in the market. Increasing R&D and new product introductions are expected to foster market growth.
The U.S. Market is Estimated at $1.3 Billion in 2021, While China is Forecast to Reach $486.7 Million by 2026
The Vascular Grafts market in the U.S. is estimated at US$1.3 Billion in the year 2021. The country currently accounts for a 40.2% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$486.7 Million in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$213.4 Million by the end of the analysis period.
Hemodialysis Access Segment to Reach $876 Million by 2026
The hemodialysis vascular graft market has been registering healthy demand, attributed to the growing prevalence of kidney diseases worldwide. Further, the rising use of biological access products on account of technological developments is also driving market growth. Rising number of patients with renal impairment and low availability of kidney donors are encouraging hemodialysis procedures in such patients, which is boosting market prospects. In the global Hemodialysis Access segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$590.8 Million in the year 2020 will reach a projected size of US$793.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$68.9 Million by the year 2026, while Latin America will expand at a 4.9% CAGR through the analysis period.
Select Competitors (Total 44 Featured)
Maquet Holding B.V. & Co. KG
Medtronic PLC
Terumo Cardiovascular Group
B. Braun Melsungen AG
BARD, A Becton, Dickinson Company
Cardinal Health, Inc.
Cook Medical LLC
Endologix, Inc.
Gore Medical
LeMaitre Vascular, Inc.
Read the full report: https://www.reportlinker.com/p05896475/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
A Prelude to Vascular Grafting
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
COVID-19 and Vascular Grafts Market
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed in 2021
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Impact of COVID-19 Outbreak on Elective Surgeries
Global Market Prospects and Overview
Vascular Grafts Market Set for a Rapid Growth
Endovascular Stent-Grafts Account for Larger Share
Competition
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Incidence of Cardio Vascular Disease Bodes Well for
the Global Vascular Graft Market
EXHIBIT 2: Fatalities by Heart Conditions: Estimated Percentage
Breakdown for Cardiovascular Disease, Ischemic Heart Disease,
Stroke, and Others
EXHIBIT 3: Global Annual Medical Cost of CVD in US$ Billion:
(2010-2030)
Rising Preference for Minimally Invasive Procedures Boosts
Market Prospects
Rising Prevalence of Kidney Diseases Drives the Global
Hemodialysis Vascular Graft Market
Hemodialysis Remains the Major Modality for Dialysis Treatment -
A Key Opportunity
EXHIBIT 4: Global Dialysis Patient Population Distribution by
Modality for Select Countries (2020): Percentage Breakdown of
Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients
EXHIBIT 5: Global Population of ESRD Patients Undergoing
Therapy by Type of Treatment (2020): Percentage Breakdown of
Patients Receiving Hemodialysis, Kidney Transplants, and
Peritoneal Dialysis
Home Hemodialysis: A Niche Albeit High Potential Market
EXHIBIT 6: World Dialysis Clinics Market by Region (2019):
Percentage Breakdown of Patients Treated by Type of Operator
EXHIBIT 7: Global Dialysis Market by Region: Percentage
Breakdown of Patients Receiving Dialysis Treatment in In-
Centre and Home Settings for 2019
Aging Population Drives Demand for Vascular Grafts
Increasing Healthcare Expenditure to Foster Growth
EXHIBIT 8: World Healthcare Expenditure (In US$ Trillion) for
the Years 2016 & 2018
Rising Middle Class Population Aids Growth
EXHIBIT 9: Global Middle Class Population (in Millions) and as
a Percentage of Total Population: 2005, 2015, 2025 & 2035
EXHIBIT 10: Global Middle Class Spending (in US$ Trillion) by
Geographic Region
Risk of CAD in Obesity Offers Prospects for Coronary Stenting
EXHIBIT 11: Obesity Prevalence Rate (%) in Select Countries for
the Years 2019 and 2030P
Cell-Free Tissue Engineered Vascular Grafts Aid in Vascular
Remodelling
Cells for Cells Develops VEINTIS?
New Approach for Optimizing TEVGs
3D Printed Vascular Scaffolds Hold Potential to be the New-Age
TEVGs
A Review of Select Vascular Developments
Some of the important vascular innovations expected in the
near-term include:
Offerings of Moving Analytics and Vasctrac
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Vascular Grafts by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 2: World Historic Review for Vascular Grafts by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Vascular Grafts by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027
Table 4: World Current & Future Analysis for Endovascular
Aneurysm Repair (EVAR) by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Endovascular Aneurysm Repair
(EVAR) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Endovascular Aneurysm
Repair (EVAR) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 7: World Current & Future Analysis for Peripheral
Vascular Repair by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Peripheral Vascular Repair
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Peripheral Vascular
Repair by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 10: World Current & Future Analysis for Hemodialysis
Access by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Hemodialysis Access by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Hemodialysis Access by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 13: World Current & Future Analysis for Polyester by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Polyester by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 15: World 15-Year Perspective for Polyester by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 16: World Current & Future Analysis for ePTFE by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for ePTFE by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 18: World 15-Year Perspective for ePTFE by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 19: World Current & Future Analysis for Polyurethane by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for Polyurethane by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 21: World 15-Year Perspective for Polyurethane by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 22: World Current & Future Analysis for Biosynthetic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 23: World Historic Review for Biosynthetic by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 24: World 15-Year Perspective for Biosynthetic by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 25: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 26: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 27: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 28: World Current & Future Analysis for Ambulatory
Surgical Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 29: World Historic Review for Ambulatory Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Ambulatory Surgical
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
III. MARKET ANALYSIS
UNITED STATES
Table 31: USA Current & Future Analysis for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 32: USA Historic Review for Vascular Grafts by Indication -
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular
Repair and Hemodialysis Access Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 33: USA 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027
Table 34: USA Current & Future Analysis for Vascular Grafts by
Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 35: USA Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 36: USA 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027
Table 37: USA Current & Future Analysis for Vascular Grafts by
End-Use - Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 38: USA Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 39: USA 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
CANADA
Table 40: Canada Current & Future Analysis for Vascular Grafts
by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 41: Canada Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 42: Canada 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027
Table 43: Canada Current & Future Analysis for Vascular Grafts
by Raw Material - Polyester, ePTFE, Polyurethane and
Biosynthetic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 44: Canada Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 45: Canada 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027
Table 46: Canada Current & Future Analysis for Vascular Grafts
by End-Use - Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 47: Canada Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 48: Canada 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
JAPAN
Table 49: Japan Current & Future Analysis for Vascular Grafts
by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 50: Japan Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 51: Japan 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027
Table 52: Japan Current & Future Analysis for Vascular Grafts
by Raw Material - Polyester, ePTFE, Polyurethane and
Biosynthetic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 53: Japan Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 54: Japan 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027
Table 55: Japan Current & Future Analysis for Vascular Grafts
by End-Use - Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 56: Japan Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 57: Japan 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
CHINA
Table 58: China Current & Future Analysis for Vascular Grafts
by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 59: China Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 60: China 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027
Table 61: China Current & Future Analysis for Vascular Grafts
by Raw Material - Polyester, ePTFE, Polyurethane and
Biosynthetic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 62: China Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 63: China 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027
Table 64: China Current & Future Analysis for Vascular Grafts
by End-Use - Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 65: China Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 66: China 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
EUROPE
Table 67: Europe Current & Future Analysis for Vascular Grafts
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR
Table 68: Europe Historic Review for Vascular Grafts by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 69: Europe 15-Year Perspective for Vascular Grafts by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027
Table 70: Europe Current & Future Analysis for Vascular Grafts
by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 71: Europe Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 72: Europe 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027
Table 73: Europe Current & Future Analysis for Vascular Grafts
by Raw Material - Polyester, ePTFE, Polyurethane and
Biosynthetic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 74: Europe Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 75: Europe 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027
Table 76: Europe Current & Future Analysis for Vascular Grafts
by End-Use - Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 77: Europe Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 78: Europe 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
FRANCE
Table 79: France Current & Future Analysis for Vascular Grafts
by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 80: France Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 81: France 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027
Table 82: France Current & Future Analysis for Vascular Grafts
by Raw Material - Polyester, ePTFE, Polyurethane and
Biosynthetic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 83: France Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 84: France 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027
Table 85: France Current & Future Analysis for Vascular Grafts
by End-Use - Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 86: France Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 87: France 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
GERMANY
Table 88: Germany Current & Future Analysis for Vascular Grafts
by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 89: Germany Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 90: Germany 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027
Table 91: Germany Current & Future Analysis for Vascular Grafts
by Raw Material - Polyester, ePTFE, Polyurethane and
Biosynthetic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 92: Germany Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 93: Germany 15-Year Perspective for Vascular Grafts by
Raw Material - Percentage Breakdown of Value Sales for
Polyester, ePTFE, Polyurethane and Biosynthetic for the Years
2012, 2021 & 2027
Table 94: Germany Current & Future Analysis for Vascular Grafts
by End-Use - Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 95: Germany Historic Review for Vascular Grafts by
End-Use - Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 96: Germany 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
ITALY
Table 97: Italy Current & Future Analysis for Vascular Grafts
by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 98: Italy Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 99: Italy 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027
Table 100: Italy Current & Future Analysis for Vascular Grafts
by Raw Material - Polyester, ePTFE, Polyurethane and
Biosynthetic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 101: Italy Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 102: Italy 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027
Table 103: Italy Current & Future Analysis for Vascular Grafts
by End-Use - Hospitals and Ambulatory Surgical Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 104: Italy Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05896475/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
